http://orcid.org/0000-0002-7777-0308
References
- YeQGenomic characterization and phylogenetic analysis of Zika virus circulating in the AmericasInfect. Genet. Evol.201643 43 4910.1016/j.meegid.2016.05.004
- Pettersson, J. H.-O., et al. How did Zika virus emerge in the Pacific Islands and Latin America? mBio7, e01239–16 (2016).
- GouldEPetterssonJHiggsSCharrelRde LamballerieXEmerging arboviruses: why today?One Health2017411310.1016/j.onehlt.2017.06.001
- DuffyMRZika virus outbreak on Yap Island, Federated States of MicronesiaN. Engl. J. Med.20093602536254310.1056/NEJMoa0805715
- Cao-LormeauVMGuillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-6
- de OliveiraWKZika virus infection and associated neurologic disorders in BrazilN. Engl. J. Med.20173761591159310.1056/NEJMc1608612
- KapteinSJNeytsJTowards antiviral therapies for treating dengue virus infectionsCurr. Opin. Pharmacol.2016301710.1016/j.coph.2016.06.002
- LaroccaRAVaccine protection against Zika virus from BrazilNature201653647447810.1038/nature18952
- Tebas, P., et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine—preliminary report. N.Engl. J. Med. https://doi.org/10.1056/NEJMoa1708120 (2017).
- PardiNZika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNature201754324825110.1038/nature21428
- MinorPDLive attenuated vaccines: historical successes and current challengesVirology2015479–48037939210.1016/j.virol.2015.03.032
- ShanCA live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse modelsNat. Med.20172376376710.1038/nm.4322
- DurbinAWilder-SmithAAn update on Zika vaccine developmentsExpert. Rev. Vaccines20171678178710.1080/14760584.2017.1345309
- Li X.-F., et al. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat. Commun. 9, 10.1038/s41467-018-02975-w (2018)
- MonathTPClinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infectionsVaccine2002201004101810.1016/S0264-410X(01)00457-1
- ArroyoJChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacyJ. Virol.200478124971250710.1128/JVI.78.22.12497-12507.2004
- ScottLJTetravalent dengue vaccine: a review in the prevention of dengue diseaseDrugs2016761301131210.1007/s40265-016-0626-8
- ChinRTorresiJJapanese B encephalitis: an overview of the disease and use of Chimerivax-JE as a preventative vaccineInfect. Dis. Ther.2013214515810.1007/s40121-013-0018-2
- AubryFSingle-stranded positive-sense RNA viruses generated in days using infectious subgenomic ampliconsJ. Gen. Virol.2014952462246710.1099/vir.0.068023-0
- SirohiDThe 3.8Å resolution cryo-EM structure of Zika virusScience201635246747010.1126/science.aaf5316
- BarrettPNMundtWKistnerOHowardMKVero cell platform in vaccine production: moving towards cell culture-based viral vaccinesExpert. Rev. Vaccines2009860761810.1586/erv.09.19
- GoveroJZika virus infection damages the testes in miceNature201654043844210.1038/nature20556
- LazearHMA mouse model of Zika virus pathogenesisCell Host Microbe20161972073010.1016/j.chom.2016.03.010
- SheehanKCFBlocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfectionJ. Interferon Cytokine Res.20062680481910.1089/jir.2006.26.804
- HeinzFXStiasnyKThe antigenic structure of Zika virus and its relation to other Flaviviruses: implications for infection and immunoprophylaxisMicrobiol. Mol. Biol. Rev.201781e00055-1610.1128/MMBR.00055-16
- AtiehTBarontiCde LamballerieXNougairèdeASimple reverse genetics systems for Asian and African Zika virusesSci. Rep.2016610.1038/srep39384
- XieXUnderstanding Zika virus stability and developing a chimeric vaccine through functional analysismBio20178e02134-1610.1128/mBio.02134-16
- PugachevKVHigh fidelity of Yellow fever virus RNA polymeraseJ. Virol.2004781032103810.1128/JVI.78.2.1032-1038.2004
- MonathTPSingle mutation in the Flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccinesJ. Virol.2002761932194310.1128/JVI.76.4.1932-1943.2002
- WeiskopfDHuman CD8+T-cell responses against the 4 dengue virus serotypes are associated with distinct patterns of protein targetsJ. Infect. Dis.20152121743175110.1093/infdis/jiv289
- WeiskopfDThe human CD8+T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopesJ. Virol.20158912012810.1128/JVI.02129-14
- NgonoAEMapping and role of the CD8+T cell response during primary Zika virus infection in miceCell Host Microbe201721354610.1016/j.chom.2016.12.010
- HalsteadSBAchieving safe, effective, and durable Zika virus vaccines: lessons from dengueLancet Infect. Dis.201717e378e38210.1016/S1473-3099(17)30362-6
- BradleyMPNagamineCMAnimal models of Zika virusComp. Med.2017672422525482516
- MonathTPChimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigenJ. Infect. Dis.20031881213123010.1086/378356
- MonathTPLive virus vaccines based on a Yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessmentVaccine201533627210.1016/j.vaccine.2014.10.004
- Martín-Acebes, M. A., Saiz, J.-C., Jiménez de Oya, N. Antibody-dependent enhancement and Zika: real threat or phantom menace? Front. Cell Infect. Microbiol. 8, 10.3389/fcimb.2018.00044 (2018)
- BlightKJMcKeatingJARiceCMHighly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replicationJ. Virol.200276130011301410.1128/JVI.76.24.13001-13014.2002
- AubryF‘ISA-Lation’ of single-stranded positive-sense RNA viruses from non-infectious clinical/animal samplesPLoS ONE201510e013870310.1371/journal.pone.0138703
- Atieh, T., et al. New reverse genetics and transfection methods to rescue arboviruses in mosquito cells. Sci. Rep.7, 10.1038/s41598-017-14522-6 (2017)
- ReedLJMuenchHA simple method of estimating fiftly per cent endpointsAm. J. Epidemiol.19382749349710.1093/oxfordjournals.aje.a118408
- TouretFGuiguenFTerzianCWolbachia influences the maternal transmission of the gypsy endogenous retrovirus in Drosophila melanogastermBio20145e01529-1410.1128/mBio.01529-14
- Delang, L., et al. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. Sci. Rep. 6, 10.1038/srep31819 (2016)